IP Library Granted Patent US 10,813,577
Granted Patent B2
US 10,813,577 · App. 16/790,365 · Granted Oct 27, 2020

Analyte sensor

Inventors: Mark C. Brister (Encinitas, CA); James R. Petisce (San Diego, CA); Kum Ming Woo (San Diego, CA); Victor Ha (Saint Louis, CA); Melissa A. Nicholas (Elkridge, MD); Peter C. Simpson (San Diego, CA); Matthew D. Wightlin (San Diego, CA); Steve Masterson (Encinitas, CA); John Nolting (Poway, CA); Jack Pryor (San Diego, CA); Sean Saint (San Diego, CA); Vance Swanson (San Diego, CA)
Assignee: DexCom, Inc.
A61B5/14532A61B5/0002A61B5/0004A61B5/05A61B5/1411A61B5/1473A61B5/1486A61B5/1495A61B5/14503A61B5/14507A61B5/14514A61B5/14546A61B5/14735A61B5/14865A61B5/6801A61B5/6833A61B5/6848A61B5/6849A61B5/68335A61B5/72A61B17/3468A61B5/14A61B5/145A61B5/1468A61B5/150022A61B2017/3492A61B2560/0223A61B2560/045A61B2562/18A61M5/14244A61M5/1723A61M2005/1585Y02A90/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,813,577
App. No.
16/790,365
Granted
Oct 27, 2020
Kind
B2
Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims (54)

1. A glucose monitoring system comprising:

a mounting unit configured for on-body securement to a host;

sensor electronics configured to be coupled to the mounting unit;

a transcutaneous glucose sensor comprising a conductive material at least partially coated with a membrane, at least a portion of the transcutaneous glucose sensor being configured for transcutaneous implantation in the host; and

wherein the transcutaneous glucose sensor is detachably connectable to the sensor electronics via a sealing member comprising conductive contacts for electrically coupling the transcutaneous glucose sensor to the sensor electronics;

wherein the transcutaneous glucose sensor has been sterilized with radiation sterilization separate from the sensor electronics; and

wherein the sensor electronics have been sterilized with chemical sterilization.

2. The glucose monitoring system of claim 1 , wherein the chemical sterilization comprises ethylene-oxide exposure.

3. The glucose monitoring system of claim 2 , wherein the sensor electronics are connectable to the transcutaneous glucose sensor by the host or a caretaker of the host.

4. The glucose monitoring system of claim 1 , wherein the radiation sterilizing comprises electron beam exposure.

5. The glucose monitoring system of claim 4 , wherein the electron beam exposure comprises exposure of 25 kGy to 50 kGy.

6. A method of manufacturing an analyte sensing system, the method comprising:

applying a membrane system on an electrode of a transcutaneous electrochemical analyte sensor configured for transcutaneous implantation in a host, wherein the transcutaneous electrochemical analyte sensor comprises:

an ex vivo portion configured to remain outside of a body of the host during a sensor session; and

an in vivo portion configured to be inserted into the body of the host and remain, during the sensor session, in the body of the host, wherein the in vivo portion comprises at least a portion of the membrane, wherein the membrane system comprises a diffusion resistance domain and an enzyme domain, wherein the enzyme domain comprises an enzyme;

packaging the transcutaneous electrochemical analyte sensor;

radiation sterilizing the packaged transcutaneous electrochemical analyte sensor; and

chemically sterilizing sensor electronics separate from the transcutaneous electrochemical analyte sensor, wherein the sensor electronics are configured to be operably connected to the transcutaneous electrochemical analyte sensor.

7. The method of claim 6 , wherein the radiation sterilizing comprises gamma radiation exposure.

8. The method of claim 6 , wherein the radiation sterilizing comprises electron beam exposure.

9. The method of claim 8 , wherein the electron beam exposure comprises exposure of 25 kGy to 50 kGy.

10. The method of claim 6 , wherein the chemically sterilizing comprises gas sterilization.

11. The method of claim 10 , wherein the chemically sterilizing comprises ethylene-oxide exposure.

12. A method of sterilizing a portion of a glucose sensor system, the method comprising:

assembling a first component of the glucose sensor system, wherein the first component of the glucose sensor system comprises:

a transcutaneous glucose sensor configured for transcutaneous implantation into a body, wherein the transcutaneous glucose sensor comprises an electrode and a membrane system, wherein the membrane system has a thickness between 20 microns and 55 microns, wherein the membrane system comprises:

an enzyme domain; and

a diffusion resistance domain; and

an elastomeric sealing member and an electrical contact, wherein the elastomeric sealing member at least partially surrounds a portion of the transcutaneous glucose sensor and at least partially surrounds the electrical contact, and wherein the electrical contact comprises a material associated with a durometer hardness of from about 20 Shore A to about 80 Shore A, wherein the sealing member comprises a material associated with a durometer hardness of from about 10 Shore A to about 70 Shore A;

packaging the first component of the glucose sensor system; and

radiation sterilizing the packaged first component of the glucose sensor system by exposing the transcutaneous glucose sensor to an electron beam radiation at a dose of from 25 kGy to 50 kGy.

13. The method of claim 12 , further comprising assembling a second component of the glucose sensor system, wherein the second component comprises sensor electronics.

14. The method of claim 13 , wherein the sensor electronics are not radiation sterilized.

15. A glucose monitoring system comprising:

a first component comprising:

a transcutaneous glucose sensor configured for transcutaneous implantation into a body, wherein the transcutaneous glucose sensor comprises an electrode and a membrane system, wherein the membrane system has a thickness of from 20 microns to 55 microns, wherein the membrane system comprises:

at least one enzyme; and

at least one diffusion resistance domain; and

an elastomeric sealing member and an elastomeric electrical contact, wherein the elastomeric sealing member at least partially surrounds a portion of the transcutaneous glucose sensor and at least partially surrounds the elastomeric electrical contact, and wherein the electrical contact comprises a material associated with a durometer hardness of from about 20 Shore A to about 80 Shore A, wherein the sealing member comprises a material associated with a durometer hardness of from about 10 Shore A to about 70 Shore A;

a second component comprising sensor electronics configured to be operably connected to the transcutaneous glucose sensor; and

wherein the first component is sterilized with radiation sterilization by exposing the transcutaneous glucose sensor to an electron beam radiation at a dose of from 25 kGy to 50 kGy.

16. A glucose monitoring system comprising:

a first component comprising:

a transcutaneous glucose sensor configured for transcutaneous implantation into a body, the transcutaneous glucose sensor comprising:

an electrode; and

a membrane system comprising at least one enzyme;

an electrical contact comprising a material associated with a first durometer hardness; and

a sealing member at least partially surrounding a portion of the transcutaneous glucose sensor and at least partially surrounding the elastomeric electrical contact, the elastomeric sealing member comprising a material associated with a second durometer hardness that is less than the first durometer hardness; and

a second component comprising sensor electronics configured to be operably connected to the transcutaneous glucose sensor,

wherein the first component is sterilized with radiation sterilization by exposing the transcutaneous glucose sensor to an electron beam radiation at a dose of from 25 kGy to 50 kGy.

17. The glucose monitoring system of claim 16 , wherein the sensor electronics have been sterilized with chemical sterilization.

18. The glucose monitoring system of claim 17 , wherein the chemical sterilization comprises ethylene-oxide exposure.

19. The glucose monitoring system of claim 16 , wherein the sensor electronics are not radiation sterilized.

20. The glucose monitoring system of claim 16 , wherein the membrane system has a thickness of from 20 microns to 55 microns.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2020
From: NICHOLAS, MELISSA A.; HA, VICTOR
To: DEXCOM, INC.
Reel/Frame 053790/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: MASTERSON, STEVE; SIMPSON, PETER; WIGHTLIN, MATTHEW D.; PRYOR, JACK; SWANSON, VANCE
To: DEXCOM, INC.
Reel/Frame 052301/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: BRISTER, MARK; PETISCE, JAMES R.; WOO, KUM MING; SAINT, SEAN; NOLTING, JOHN
To: DEXCOM, INC.
Reel/Frame 051848/0435 →
Continuity (6)
Continuation 16674610 · Nov 5, 2019
Continuation 16392521 · Apr 23, 2019
Continuation 14590483 · Jan 6, 2015
Continuation 13909962 · Jun 4, 2013
Continuation 11360262 · Feb 22, 2006
Related Publication 20200196924A1 · Jun 25, 2020
Cited By (12)
US 1,076,079 US 1,086,030 US 1,130,752 US 12,187,480 US 12,279,865 US 12,303,260 US 12,446,801 US 12,490,919 US 12,543,976 US 12,642,456 US 12,666,543 US 12,714,334